gp160 mn/lai-2
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 1998 (NCT00004579)
Timeline
1990s
- Jan 1, 1998
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gp160 mn/lai-2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00031109 | N/A | Feb 25, 2002 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00006509 | Phase 1 | Nov 17, 2000 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00004579 | Phase 1 | Apr 1, 1998 | United States Army |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 2 | 2000 |
| United States Army | Government | 1 | 1 | 1 | 1998 |
2 organizations
Page 1 / 1